VWR Acquires Reliable Biopharmaceutical and BioArra
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
VWR (VWR) Tops Q3 EPS by 1c
November 3, 2016 8:59 AM EDTVWR (NASDAQ: VWR) reported Q3 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.15 billion.VWR reaffirmed FY2016 guidance.
Acquisition:
VWR also announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra, earlier today.
... More


